ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2009;87:e13-e14. doi:10.1016/j.athoracsur.2008.09.046
© 2009 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Russell W.J. Millner
Christos Alexiou
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Millner, R. W.J.
Right arrow Articles by Alexiou, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Millner, R. W.J.
Right arrow Articles by Alexiou, C.
Related Collections
Right arrow Cardiac - pharmacology

Case Reports

A New Hemostatic Agent: Initial Life-Saving Experience With Celox (Chitosan) in Cardiothoracic Surgery

Russell W.J. Millner, MD, FRCS (CTh)a,*, Alan S. Lockhart, FRCAb, Helen Bird, FRCAb, Christos Alexiou, PhD, FRCS (CTh)a

a Department of Cardiothoracic Surgery, Blackpool Victoria Hospital, Blackpool, United Kingdom
b Department of Cardiothoracic Anesthesia, Blackpool Victoria Hospital, Blackpool, United Kingdom

Accepted for publication September 11, 2008.

* Address correspondence to Dr Millner, Department of Cardiothoracic Surgery, Blackpool Victoria Hospital, Whinney Heys Rd, Blackpool, FY3 8NR, United Kingdom (Email: russellmillner{at}btinternet.com).

Celox (MedTrade Products Ltd, Cheshire, UK) is a proprietary preparation of chitosan, indicated for moderate to severe hemorrhage and currently used for hemostasis in the emergency and military settings. We describe its lifesaving use in 2 patients undergoing cardiothoracic surgery in which conventional techniques had failed.




This article has been cited by other articles:


Home page
 Interact CardioVasc Thorac SurgHome page
J. Hajj-Chahine
eComment. Activated recombinant factor VII in intractable bleeding after cardiac surgery
Interact CardioVasc Thorac Surg, June 1, 2012; 14(6): 698 - 698.
[Full Text] [PDF]

Home page
 Interact CardioVasc Thorac SurgHome page
L. Muzzi, G. Tommasino, E. Tucci, and E. Neri
Successful use of a military haemostatic agent in patients undergoing extracorporeal circulatory assistance and delayed sternal closure
Interact CardioVasc Thorac Surg, June 1, 2012; 14(6): 695 - 698.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
V. A. Ferraris, J. R. Brown, G. J. Despotis, J. W. Hammon, T. B. Reece, S. P. Saha, H. K. Song, E. R. Clough, L. J. Shore-Lesserson, L. T. Goodnough, et al.
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
Ann. Thorac. Surg., March 1, 2011; 91(3): 944 - 982.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. Barnard and R. Millner
A Review of Topical Hemostatic Agents for Use in Cardiac Surgery
Ann. Thorac. Surg., October 1, 2009; 88(4): 1377 - 1383.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The Society of Thoracic Surgeons.